Mercer Global Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.84M | Buy |
33,535
+3,791
| +13% | +$208K | ﹤0.01% | 891 |
|
2025
Q1 | $2.1M | Buy |
29,744
+11,641
| +64% | +$823K | ﹤0.01% | 827 |
|
2024
Q4 | $1.19M | Buy |
18,103
+9,915
| +121% | +$652K | ﹤0.01% | 1024 |
|
2024
Q3 | $574K | Sell |
8,188
-3,980
| -33% | -$279K | ﹤0.01% | 1263 |
|
2024
Q2 | $1.01M | Sell |
12,168
-104
| -0.8% | -$8.61K | ﹤0.01% | 960 |
|
2024
Q1 | $1.07M | Sell |
12,272
-263
| -2% | -$23K | ﹤0.01% | 935 |
|
2023
Q4 | $1.21M | Sell |
12,535
-180
| -1% | -$17.4K | ﹤0.01% | 901 |
|
2023
Q3 | $1.13M | Sell |
12,715
-2,839
| -18% | -$251K | ﹤0.01% | 898 |
|
2023
Q2 | $1.35M | Sell |
15,554
-60
| -0.4% | -$5.2K | 0.01% | 843 |
|
2023
Q1 | $1.52M | Sell |
15,614
-679
| -4% | -$66K | 0.01% | 762 |
|
2022
Q4 | $1.69M | Sell |
16,293
-1,594
| -9% | -$165K | 0.01% | 724 |
|
2022
Q3 | $1.52M | Sell |
17,887
-1,486
| -8% | -$126K | 0.01% | 708 |
|
2022
Q2 | $1.61M | Buy |
19,373
+16
| +0.1% | +$1.33K | 0.01% | 668 |
|
2022
Q1 | $1.49M | Sell |
19,357
-7
| -0% | -$540 | 0.01% | 749 |
|
2021
Q4 | $1.71M | Buy |
19,364
+615
| +3% | +$54.3K | 0.01% | 678 |
|
2021
Q3 | $1.45M | Sell |
18,749
-5,375
| -22% | -$415K | 0.01% | 734 |
|
2021
Q2 | $2.01M | Sell |
24,124
-61
| -0.3% | -$5.09K | 0.02% | 567 |
|
2021
Q1 | $1.83M | Sell |
24,185
-2,380
| -9% | -$180K | 0.02% | 551 |
|
2020
Q4 | $2.33M | Buy |
26,565
+314
| +1% | +$27.5K | 0.03% | 390 |
|
2020
Q3 | $2M | Buy |
26,251
+23,384
| +816% | +$1.78M | 0.03% | 382 |
|
2020
Q2 | $354K | Buy |
2,867
+34
| +1% | +$4.2K | 0.01% | 796 |
|
2020
Q1 | $239K | Buy |
2,833
+14
| +0.5% | +$1.18K | 0.01% | 887 |
|
2019
Q4 | $238K | Buy |
+2,819
| New | +$238K | ﹤0.01% | 1008 |
|
2019
Q3 | – | Sell |
-2,725
| Closed | -$233K | – | 1134 |
|
2019
Q2 | $233K | Buy |
2,725
+84
| +3% | +$7.18K | 0.01% | 982 |
|
2019
Q1 | $235K | Buy |
+2,641
| New | +$235K | 0.01% | 928 |
|